Jefferies Group’s Novartis NVS Stock Holding History

Jefferies Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-44,640	Closed	-$3.45M	–	2430
2018 Q3	$3.45M	Buy	44,640 +9,263	+26%	+$685K	0.02%	713
2018 Q2	$2.4M	Buy	35,377 +21,204	+150%	+$1.46M	0.01%	804
2018 Q1	$1.03M	Buy	+14,173	New	+$1.08M	0.01%	1186
2017 Q3	–	Sell	-8,370	Closed	-$626K	–	2544
2017 Q2	$626K	Sell	8,370 -21,762	-72%	-$1.54M	﹤0.01%	1513
2017 Q1	$2M	Buy	+30,132	New	+$2.01M	0.01%	912
2014 Q4	–	Sell	-26,672	Closed	-$2.25M	–	2236
2014 Q3	$2.25M	Buy	+26,672	New	+$2.16M	0.02%	685
2014 Q1	–	Sell	-26,561	Closed	-$1.91M	–	2280
2013 Q4	$1.91M	Buy	+26,561	New	+$1.85M	0.01%	594

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jefferies Group's NVS Position: Q1 2020 in Review

Jefferies Group sold out of Novartis (NVS) in Q1 2020, closing a stake of 6,896 shares — an estimated $653K sold.

Jefferies Group first reported a position in NVS in Q4 2013 and held it in 13 quarters. The position peaked at $6.24M in Q2 2018. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

Jefferies Group reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 6,896 Novartis shares in Q1 2020, an estimated $653K.
Jefferies Group first reported a position in Novartis in Q4 2013 and held it in 13 quarters.
Jefferies Group's Novartis position peaked at $6.24M in Q2 2018.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.